Healthcare provider profile · identity verified

Trenton Ryan Johnson

Physician Assistant · CLENDENIN, WV · NPI 1831798321

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	437	138
Lisinopril	Lisinopril	312	103
Amlodipine Besylate	Amlodipine Besylate	311	97
Omeprazole	Omeprazole	297	95
Metoprolol Succinate	Metoprolol Succinate	285	88
Levothyroxine Sodium	Levothyroxine Sodium	252	69
Pantoprazole Sodium	Pantoprazole Sodium	229	80
Losartan Potassium	Losartan Potassium	203	64
Albuterol Sulfate Hfa	Albuterol Sulfate	192	79
Prednisone	Prednisone	191	146
Gabapentin	Gabapentin	182	30
Tamsulosin Hcl	Tamsulosin Hcl	151	56
Pravastatin Sodium	Pravastatin Sodium	141	39
Metformin Hcl	Metformin Hcl	128	41
Metformin Hcl Er	Metformin Hcl	123	45
Azelastine Hcl	Azelastine Hcl	122	88
Montelukast Sodium	Montelukast Sodium	119	35
Potassium Chloride	Potassium Chloride	119	42
Pregabalin	Pregabalin	119	18
Clopidogrel	Clopidogrel Bisulfate	118	37
Rosuvastatin Calcium	Rosuvastatin Calcium	117	43
Fluticasone Propionate	Fluticasone Propionate	116	41
Jardiance	Empagliflozin	112	36
Glipizide Er	Glipizide	108	48
Tramadol Hcl	Tramadol Hcl	99	15
Simvastatin	Simvastatin	97	33
Famotidine	Famotidine	96	30
Sertraline Hcl	Sertraline Hcl	91	21
Furosemide	Furosemide	90	37
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	88	25
Chlorthalidone	Chlorthalidone	86	27
Carvedilol	Carvedilol	82	28
Duloxetine Hcl	Duloxetine Hcl	81	30
Donepezil Hcl	Donepezil Hcl	79	33
Ezetimibe	Ezetimibe	77	28
Ibuprofen	Ibuprofen	77	27
Amitriptyline Hcl	Amitriptyline Hcl	69	26
Farxiga	Dapagliflozin Propanediol	65	21
Buspirone Hcl	Buspirone Hcl	64	26
Torsemide	Torsemide	64	30
Hydrochlorothiazide	Hydrochlorothiazide	63	18
Ozempic	Semaglutide	63	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	61	56
Doxycycline Hyclate	Doxycycline Hyclate	61	53
Glimepiride	Glimepiride	60	22
Trazodone Hcl	Trazodone Hcl	60	19
Fenofibrate	Fenofibrate	59	24
Symbicort	Budesonide/Formoterol Fumarate	58	16
Allopurinol	Allopurinol	56	16
Diclofenac Sodium	Diclofenac Sodium	54	32
Hydroxyzine Hcl	Hydroxyzine Hcl	53	21
Metoprolol Tartrate	Metoprolol Tartrate	53	19
Ventolin Hfa	Albuterol Sulfate	53	18
Fluoxetine Hcl	Fluoxetine Hcl	52	14
Eliquis	Apixaban	50	19
Fluconazole	Fluconazole	50	28
Trulicity	Dulaglutide	49	16
Alendronate Sodium	Alendronate Sodium	48	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	14
Methocarbamol	Methocarbamol	45	24
Oxybutynin Chloride Er	Oxybutynin Chloride	45	17
Tizanidine Hcl	Tizanidine Hcl	44	16
Nitroglycerin	Nitroglycerin	43	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	21
Mounjaro	Tirzepatide	39	13
Meloxicam	Meloxicam	37	15
Escitalopram Oxalate	Escitalopram Oxalate	36	14
Benazepril Hcl	Benazepril Hcl	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Mupirocin	Mupirocin	34	22
Naproxen	Naproxen	34	13
Triamcinolone Acetonide	Triamcinolone Acetonide	34	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	33	suppressed
Spironolactone	Spironolactone	33	13
Venlafaxine Hcl Er	Venlafaxine Hcl	33	12
Paroxetine Hcl	Paroxetine Hcl	32	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	17
Memantine Hcl	Memantine Hcl	31	12
Ondansetron Odt	Ondansetron	30	20
Sumatriptan Succinate	Sumatriptan Succinate	28	11
Bupropion Xl	Bupropion Hcl	27	suppressed
Finasteride	Finasteride	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	13
Ramipril	Ramipril	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	22
Hydrocortisone	Hydrocortisone	25	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Nystatin	Nystatin	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	14
Topiramate	Topiramate	21	suppressed
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	17
Alprazolam	Alprazolam	18	suppressed
Atenolol	Atenolol	18	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error